Venture

Virtus Therapeutics is developing a novel class of small molecules which stimulate Coenzyme A production to treat the debilitating, rare, pediatric disease, Pantothenate Kinase-Associated Neurodegeneration.

Virtus Therapeutics Team:

Jessica Regan

Prisca Obi